These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
4. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296 [TBL] [Abstract][Full Text] [Related]
5. A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment. Bellat V; Alcaina Y; Tung CH; Ting R; Michel AO; Souweidane M; Law B Neuro Oncol; 2020 Oct; 22(10):1495-1504. PubMed ID: 32301996 [TBL] [Abstract][Full Text] [Related]
6. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report. Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124 [TBL] [Abstract][Full Text] [Related]
7. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study. Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal Monitoring of Gd-DTPA Following Convection Enhanced Delivery in the Brainstem. Tosi U; Souweidane MM World Neurosurg; 2020 May; 137():38-42. PubMed ID: 32028001 [TBL] [Abstract][Full Text] [Related]
10. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma. Arms LM; Duchatel RJ; Jackson ER; Sobrinho PG; Dun MD; Hua S J Control Release; 2024 Jun; 370():835-865. PubMed ID: 38744345 [TBL] [Abstract][Full Text] [Related]
11. A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an Wang M; Kommidi H; Tosi U; Guo H; Zhou Z; Schweitzer ME; Wu LY; Singh R; Hou S; Law B; Ting R; Souweidane MM Mol Cancer Ther; 2017 Dec; 16(12):2902-2912. PubMed ID: 28978723 [TBL] [Abstract][Full Text] [Related]
12. Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma. Sasaki T; Katagi H; Goldman S; Becher OJ; Hashizume R Neurosurgery; 2020 Nov; 87(6):E680-E688. PubMed ID: 32674144 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas. Gibson EG; Campagne O; Selvo NS; Gajjar A; Stewart CF Cancer Chemother Pharmacol; 2021 Dec; 88(6):1009-1020. PubMed ID: 34586478 [TBL] [Abstract][Full Text] [Related]
14. PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma. Mueller S; Kline C; Stoller S; Lundy S; Christopher L; Reddy AT; Banerjee A; Cooney TM; Raber S; Hoffman C; Luks T; Wembacher-Schroeder E; Lummel N; Zhang Y; Bonner ER; Nazarian J; Molinaro AM; Prados M; Villanueva-Meyer JE; Gupta N Neuro Oncol; 2023 Nov; 25(11):2074-2086. PubMed ID: 37318058 [TBL] [Abstract][Full Text] [Related]
15. The intersect of neurosurgery with diffuse intrinsic pontine glioma. Kuzan-Fischer CM; Souweidane MM J Neurosurg Pediatr; 2019 Dec; 24(6):611-621. PubMed ID: 31786541 [TBL] [Abstract][Full Text] [Related]
16. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma. Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR J Neurosurg Pediatr; 2019 Mar; 23(3):333-342. PubMed ID: 30544335 [TBL] [Abstract][Full Text] [Related]
17. Deformational changes after convection-enhanced delivery in the pediatric brainstem. Bander ED; Tizi K; Wembacher-Schroeder E; Thomson R; Donzelli M; Vasconcellos E; Souweidane MM Neurosurg Focus; 2020 Jan; 48(1):E3. PubMed ID: 31896089 [TBL] [Abstract][Full Text] [Related]
18. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial. McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP J Neurosurg Pediatr; 2021 Oct; 28(4):371-379. PubMed ID: 34359048 [TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851 [TBL] [Abstract][Full Text] [Related]
20. Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma. Lian X; Kats D; Rasmussen S; Martin LR; Karki A; Keller C; Berlow NE Acta Neuropathol Commun; 2021 May; 9(1):88. PubMed ID: 34001278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]